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CYTOCHALASIN B REVERSIBLY INHIBITS PHAGOCYTOSIS:
FUNCTIONAL, METABOLIC, AND ULTRASTRUCTURAL EFFECTS
IN HUMAN BLOOD LEUKOCYTES AND RABBIT ALVEOLAR MACROPHAGESt
Phagocytosis involves several specific sequential and overlapping activities,
which include contact between particle and cell, ingestion, increased meta-
bolic activity, fusion of lysosomal structures with the vacuoles containing
ingested material, and intracellular killing and digestion. The techniques for
separating these activities may distinguish those that are causally related
from others that are merely associated, and may reveal the specific pathways
involved.
In human polymorphonuclear leukocytes (PMN), for example, colchicine
and vinblastine are known to cause the disruption of normal microtubules.856
These agents also interfere with lysosomal degranulation and the formation
of digestive vacuoles in PMN, without altering particle ingestion and intra-
cellular killing. Thus, microtubules may facilitate the association of lyso-
somes with vacuoles containing the ingested material.`"
The recently introduced mold metabolite, cytochalasin B, may provide an
opportunity to dissect the phagocytic process further. This agent also affects
certain types of motility, of cells and within cells,'1 and may specifically in-
terfere with the function of contractile systems of microfilaments, as dis-
tinguished from microtubules."' In order to study the possible role of mi-
crofilaments in phagocytosis, we examined the effects of cytochalasin B on
phagocytosis of bacteria by human blood leukocytes and rabbit alveolar
macrophages.
MATERIALS AND METHODS
Human blood leukocytes. As described previously,' heparinized venous blood was
sedimented in 2 volumes of 3 percent dextran, and the leukocyte-rich supernatant was
sedimented and washed in modified Krebs-Ringer phosphate buffer, pH 7.4. The cells
were osmotically shocked (to lyse red cells), restored to isotonicity, washed once more
in buffer, counted, and adjusted to about 3 X 107 white blood cells (WBC) per ml.
Differential counts were performed.
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Rabbit alveolar macrophages. As described previously,' alveolar macrophages were
harvested in Krebs-Ringer phosphate buffer, pH 7.4, containing 5.5 mM glucose. The
average yield was 1 X 108 cells per rabbit.
Bacteria. Staphylococcus aureus strain 502A1 was shaken overnight in beef heart in-
fusion broth at 37°C, centrifuged, and washed once in normal saline, and the bacteria
were suspended in albumin (10 mg/100 ml) buffer. The concentration of staphylococci
was estimated from a constructed curve of transmittance at 600m,u and confirmed by
quantitative plating in agar. For metabolic studies heat-killed staphylococci"5 were
used.
Drugs. Cytochalasin B (Imperial Chemical Industries, Ltd., Macclesfield, Cheshire,
England; mol. wt. 479) was dissolved in dimethylsulfoxide (DMSO spectranalyzed,
Fisher Scientific Co., Pittsburgh, Pa.) at a concentration of 3 mg/ml. Aliquots were
stored at minus 70°C until use, at which time they were diluted in aqueous media. In
most experiments, DMSO was used as an additional control in at least the concentra-
tion at which it was present with cytochalasin B (and sometimes two-to-four times
that concentration).
Phagocytosis. Leukocytes in 12 percent autologous serum-heparinized buffer, with
or without cytochalasin B and DMSO, were shaken in an Eberbach Incubator Model
6250 (Eberbach Corp., Ann Arbor, Michigan), 100 reciprocations per minute, at 37°C
for 10 minutes. Then bacteria were added (0 time), and the incubation continued.
Duplicate samples were taken at intervals of 20 and 40 minutes, and the cells were
separated from the media by centrifugation and washing. Both the bacteria remaining
in the supernatants and the cell-associated live bacteria were enumerated to determine,
respectively, uptake and killing of bacteria by leukocytes. Bacteria were also enumerated
after incubation in serum-buffer without white cells. The detailed procedures were as
previously described.9" Experiments were done in 25-ml Erlenmeyer flasks, with total
volumes of 2.8, 4.2, or 5.6 ml, and at various ratios of staphylococci to polymorphonu-
clear leukocytes.
In experiments designed to test the reversibility of effects of cytochalasin B, aliquots
of cells, one with cytochalasin B, 2 ,ug/ml, were shaken in 35 ml centrifuge tubes at
37°C for 10 minutes. Then all were diluted, washed, resuspended in flasks, and again
incubated, one (other) with cytochalasin B, 2 ,ug/ml, and then all with bacteria, and
samples taken as usual.
After a series of preliminary experiments to establish good conditions for incubation
of alveolar macrophages, studies were done like those designed to detect reversibility
with human leukocytes, except that (a) the concentration of cytochalasin B was in-
creased from 2 Atg/ml to 5 ,g/ml, (b) the time of each preincubation with drug was
increased from 10 minutes to 20 minutes, (c) the times of (duplicate) sampling after
addition of bacteria were changed to 30 and 60 minutes, and (d) there were five flasks
containing cells: two control, two that received the drug after the wash, and one that
received it before the wash.
Metabolic studies. In leukocytes, the oxidation of glucose-1-"C was measured as de-
scribed previously.' In macrophages, the oxidations of glucose-1-"'C, glucose-6-14C,
pyruvate-1-"C, acetate-1-"4C, and succinate-1-"`C, were all measured as described pre-
viously.,
Enzyme studies. Glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphoglu-
conate dehydrogenase (6 PGD) were measured by the methods of Strauss et al.'7 Units
of either enzyme represent mgs moles NADP reduced/minute/106 cells.
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Morphology. Samples of either cell type at various intervals were centrifuged directly
on to glass (Shandon Cytocentrifuge, Shandon Scientific Co., Inc., Sewickley, Penna.)
and stained with Wright's stain. Other samples were added to an equal volume of 2
percent buffered glutaraldehyde solution, pH 7.3, centrifuged and overlayed with more
fixative. Later they were rinsed briefly in buffered, isotonic sucrose solution, post-fixed
in OsO., dehydrated and embedded in Maraglas."8'2' Ultrathin sections, having been
stained with uranyl and lead salts,' were studied in an Elmiskop 101 electron micro-
scope. One-micron-thick sections of the plastic-embedded tissue were stained with
metachromatic dyes and examined by conventional and phase microscopy.
Statistics. The t test for paired variates was used throughout.
RESULTS
The effects of cytochalasin B on the uptake and killing of staphylococci
by human blood leukocytes.
Compared to controls treated with DMSO, cytochalasin B (2 or 5 jtg/ml)
inhibited the disappearance of bacteria from the supernatant after both 20
and 40 minutes of incubation (Fig. 1; mean values are depicted, + SEM).
These findings were consistent over a range of ratios of bacteria to PMN
that varied from 4:1 to 39:1 (mean 17:1, median 18:1, mode 18:1). Since
cytochalasin B did not affect the recovery of bacteria from control flasks
incubated without leukocytes, the observed difference represents a decreased
uptake of bacteria by cells. Although the drug-treated cells took up fewer
bacteria than their controls, 40-minute samples of cells treated with 5 ug/
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ml cytochalasin B yielded significantly more live bacteria than their controls
(Fig. 1). This finding indicates either that bacteria were adherent to treated
cells but not ingested, or were ingested but not normally killed, or both.
DMSO in these concentrations (' .17%o) had only a small effect on the
uptake of bacteria by cells. When DMSO-treated flasks were compared to
no-drug controls (not depicted in Fig. 1), supernatants from 20-minute
samples contained a small but significant increase in the mean percentage
of the inoculum remaining (38 + 4.5 [SEM] vs. 33 + 4.0; n 12,
p < .05); differences at 40 minutes were no longer significant (11 ± 1.7
vs. 10-+- 1.4 n= 12,p > .1).
Reversibility. In four experiments (see Methods) the effect of cyto-
chalasin B on the uptake of bacteria by leukocytes appeared to be reversi-
ble. The mean percentages of the inoculum remaining in the supernatant,
+ SEM, from flasks given the drug after the wash, versus no-drug controls,
were 65 + 12.3 vs. 42 + 6.3 (p < .05) at 20 minutes, and 32 + 9.6 vs.
15 ± 7.7 (p < .01) at 40 minutes. In contrast, from flasks where the drug
was applied before the wash, values were similar to controls: 43 + 6.8 at
20 minutes, and 18 + 8.5 at 40 minutes. Ratios of bacteria: PMN varied
from 16 to 21:1.
The effects of cytochalasin B on the uptake and killing of staphylococci by
rabbit alveolar macrophages.
In each of four studies (see Methods), the results were consistent; mean
values, ± SEM, from the eight paired flasks (control vs. drug-after-wash)
are depicted in Fig. 2. (The 60-minute supernatants were inadvertantly lost
in one study; thus n 6 at that point). At each interval there is both
diminished uptake of bacteria from the supernatant, and diminished killing
by cells that were treated with drug after the wash. Ratios of bacteria:
macrophage varied from 11 to 17:1.
Reversibility. Cells treated with cytochalasin B before being washed,
subsequently behaved similar to control cells (Fig. 2).
The effect of cytochalasin B on the production of 14CO2 from labelled
glucose and from other labelled substrates.
The increase in production of 14CO2 from glucose-1-14C via the pentose
shunt pathway, that follows the addition of bacteria to control human leuko-
cytes, was diminished in cells treated with cytochalasin B (Table 1). In two
experiments in which cytochalasin B, 5 jug/ml, was used, values for treated
cells were less than 5%o those of controls (Experiments 1 and 2, Stimulated
Cells). This inhibition was dosage-dependent, and was significant with as
little as 0.5 jug/ml cytochalasin B (Experiments 3-6, Stimulated Cells). The
inhibition was similar when the period of incubation was extended from 20
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to 40 min. (Experiment 5). DMSO had no appreciable inhibitory effect
(Experiments 1 and 2).
A similar though less pronounced effect of cytochalasin B to that in stimu-
lated cells could be demonstrated in leukocytes incubated without bacteria
(Table 1, Resting Cells).
Because the alveolar macrophage contains a complement of metabolic
machinery some of which is only rudimentary in the mature PMN,'2'" we
tested various substrates in macrophages-resting and stimulated-treated
with cytochalasin B. For the oxidation of glucose-1-14C, there was once
again significantly less 14C02 from both stimulated and resting cells treated
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FIG. 2. Cytochalasin B inhibits the uptake and killing of staphylococci by rabbit al-
veolar macrophages.
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with cytochalasin B (2 ug/ml) than from their respective controls (Fig. 3).
Effects on the oxidation of glucose-6-14C were similar (Fig. 3) but signifi-
cantly less marked. Thus, in stimulated cells treated with cytochalasin B,
the release of 14CO2 compared to controls was 30%o from glucose-1-_4C and
65% from glucose-6-_4C (p < 0.025).
Cytochalasin B, 2 pg/ml, had no significant inhibitory effect on the re-
lease of 14CO2 from pyruvate-1-_4C, acetate-1-14C, or succinate-1-14C, in
either resting or stimulated cells (Table 2).
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Reversibility of the effect of cytochalasin B on the production of 14CO,
from glucose-1-14C. When bacteria were presented to cells, either leukocytes
or macrophages, previously incubated with cytochalasin B and then washed,
the production of '4CO2 from glucose-1-14C was similar to that from controls
that had not received cytochalasin B (Table 3, Before Wash). Stimulated
cells that received cytochalasin B after the wash, released only 13% to 23%o
as much 14CO2 as did controls. Thus this metabolic effect of cytochalasin B
appears to be reversible in both leukocytes and macrophages.
The lack of inhibition by cytochalasin B of the activities of glucose-6-
phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase
(6 PGD). In view of the inhibition of pentose shunt activity in the leuko-
cyte and the preferential reduction in 14CO2 production from glucose-1-14C
TABLE 2. CYTOCHALASIN B DOES NOT INHIBIT THE PRODUCTION OF 1CO2
FROM LABELLED PYRUVATE, ACETATE AND SUCCINATE
Resting CellsA Stimulated CelisA
Cyt. B, 2 g/ml - + - +
Pyruvate-1-'C (1) 23 ± 2.1 33 + 3.1 34 + 3.7 48 ± 5.1
(2) 20 ±3.1 30±2.9 30±3.7 43 3.9
Acetate-l-"C (1) 38* ± 3.1 43 ± 5.1 36 + 5.2 45 + 7.3
(2) 18 ±3.2 29 3.1 33 ±4.1 34±5.2
Succinate-l-'C (1) 11 ± 3.7 13 ± 2.1 14 ± 2.1 15 ± 2.2
(2) 27 ±3.1 23 ±3.0 25 +2.7 24± 1.8
Acpm/IX1O1 cells/60 min.; average counts from triplicate flasks, + SEM.
* Duplicate flasks.
TABLE 3. REVERSIBILITY OF THE EFFECT OF CYTOCHALASIN B ON THE
PRODUCTION OF "CO2 FROM GLUCOSE-1-"'C
Stimulated CellsA
Human Blood Rabbit Alveolar
Leukocytes* Macrophages+
(1) (2) (3) (1) (2)
Control (No Cyt. B) 77 62 85 95 110
Cyt. B, 2 pg/ml, Before wash 87 56 87t 84 99
Cyt. B, 2 ,g/ml, After wash 9 10 18t 22 23
Ratio, Bacteria: Cell 20:1 12:1 12:1 150:1 150:1
A Aliquots of cells were incubated, some with cytochalasin B, then diluted, washed,
resuspended, and again incubated, some with cytochalasin, and then all with glucose-l-
"C and heat-killed staphylococci (see Methods).
* cpm (X10)/3X107 cells/20 min.; average counts from triplicate flasks.
+cpm/1X10 cells/60 min.; average counts from triplicate flasks.
: Duplicate flasks only.
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over that from glucose-6-14C in the macrophage, the effects of cytochalasin
B on two important enzymes in the pentose shunt were examined. In two
experiments with homogenates of macrophages, mean values for G6PD
without and with added cytochalasin B (5 jug/ml) were 3.62 and 3.80 units,
respectively. In five experiments, the mean values for 6 PGD were 1.01
and 1.16 units respectively. DMSO in corresponding dilution had no effect
on activities of either enzyme.
Structural and ultrastructural observations
The diminished uptake of bacteria by cells treated with cytochalasin B
was frequently confirmed by examining samples centrifuged on to glass
slides and stained (Figs. 4 and 5). In addition to having fewer cell-associ-
ated bacteria than controls or DMSO-treated cells, drug-treated PMN
could be identified by the tendency of their cytoplasm to spread more upon
the glass than that of untreated cells, and of the lobes of their nuclei to be
less mutually constrained, producing a rosette effect when viewed at low
power (Fig. 3). Drug-treated macrophages tended also to spread out more
than their controls, and to lose their normal three-dimensional appearance;
whatever cell-associated bacteria were present appeared to be primarily in
one plane (Fig. 5).
In one-micron-thick sections, diminished numbers of intracellular bacteria
could be counted in drug-treated cells compared to controls. For example,
in one experiment the mean number of bacteria per control PMN slice
(n = 20 slices) after 40 minutes of incubation was 7.4 + 0.6 (SEM),
versus 1.2 ± 0.3 per slice from drug-treated cells (Figs. 6 and 7). In an-
other, there were 7.0 + 0.5 bacteria per macrophage slice (n = 20, 60
minutes of incubation) versus 5.0 + 0.4 from drug-treated cells (5 jug/ml,
20-minute preincubation).
PMN treated with cytochalasin B frequently showed partial engulfment
of bacteria as depicted in Fig. 8, an observation that was rarely made on
control cells. Control cells, on the other hand, contained proportionally more
and larger digestive vacuoles (often containing partly digested micro-or-
ganisms) than did drug-treated cells. However, in treated cells, fusion of
leukocyte granules with phagocytic vacuoles (phagosomes) was on occasion
definitely observable.
The hyaloplasm of control leukocytes contained their usual, scant com-
plement of centrioles, microtubules and skeins of microfilaments (Fig. 9).
Filaments were not seen in PMN treated with cytochalasin B (Fig. 8).
Similarly, there was a pronounced decrease in the incidence of microfila-
ments in drug-treated macrophages compared to controls (Figs. 10 and 11);
however, microtubules remained prominent in drug-treated cells (Fig. 11).
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FIG. 4. The effect of cytochalasin B on human blood leukocytes inoculated with bac-
teria for 20 minutes is seen in cells centrifuged on to glass slides. (A) No drug. Many
bacteria per cell are seen. (B) Cytochalasin B, 5 ,ug/ml, 10 minute preincubation. Fewer
bacteria per cell are seen, cells appear more spread out than in (A), and lobes of PMN
nuclei show the rosette effect (arrows). Wright's stain. (Taken from ref. 1).
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'sAr.",FIG. 5. The effect of cytochalasin B on rabbit alveolar macrophages incubated with
bacteria for 60 minutes is seen in cells centrifuged on to glass slides. (A) No drug.
Many bacteria per cell are seen. The cells have depth; bacteria are in different planes.
(B) Cytochalasin B, 5 ,ug/ml, 10 minute preincubation. FewNer bacteria per cell are
seen, and the cells appear flatter and more spread out than in (A). Wright's stain.f
FIG. 6. Control leukocytes (no drug) incubated with bacteria for 40 minutes contain
numerous ingested bacteria in varying stages of digestion. The arrows point at vacuoles
with partly hydrolzed micro-organisms; the large, "empty" digestive vacuoles most
likely represent final-stage digestive vacuoles in which bacteria have been completely
hydrolzed. Mag: 9,000 X.
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FIG. 7. Leukocytes exposed to 5 pg/ml cytochalasin B (10 minute preincubation)
and incubated with bacteria for 40 minutes, typically show fewer intracellular bacteria.
Note also their full complement of leukocyte granules. Mag: 9,000 X.
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FIG. 8. Part of a leukocyte exposed to cytochalasin B as in Fig. 7. The depicted par-
tial or nearly complete engulfment of bacteria was observed with many of the treated
cells. Note the finely granular cytoplasm devoid of microfilaments. Mag: 33,000 X.(
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(
FIG. 9. In contrast to Fig. 8, part of a control leukocyte contains, aside from a bac-
terium, skeins of microfilaments (insert). A centriole (arrow) and microtubules are
also visible. Mag: 22,000 X. Insert mag: 50,000 X.K-
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FIG. 10. Part of a control macrophage, incubated with bacteria for 60 minutes, shows
ingested micro-organisms (lower margin of illustration). Note the abundant micro-
tubules (arrow) and microfilaments (insert) which are particularly prominent in the
upper one-third of the illustration. Mag: 30,000 X. Insert mag: 50,000 X.
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FIG. 11. Part of a macrophage exposed to 5 ,ug/ml cytochalasin B (20 minute pre-
incubation) and incubated with bacteria for 60 minutes is seen. Microfilaments are not
observable, but microtubules are prominent (arrow); a centrole is present on the left
margin of the photograph (double arrow). Mag: 35,000 X.Cytochalasin B inhibition of phagocytosis M
DISCUSSION
Uptake and killing of bacteria. Cytochalasin B produced a decrease in
the uptake of Staphylococcus aureus by both human blood leukocytes and
rabbit alveolar macrophages (Figs. 1 and 2). Despite diminished uptake,
however, the drug-treated cells showed more live cell-associated bacteria
than their controls, indicating either that bacteria were adherent to treated
cells but not ingested, or were ingested but not normally killed, or both.
These effects with both cell types were reversible.
Recently, Davis et al. found similar results with human PMN using a
higher concentration of cytochalasin B (10 ,ug/ml), a low ratio of bacteria:
PMN (1:1), and measuring at intervals the survival of bacteria from sam-
ples of the entire suspension (supernatant + cells).' They too found no
direct effect of cytochalasin B on the survival of staphylococci incubated
without cells, or on the ability of serum to opsonize the bacteria. They also
added penicillin and streptomycin to the medium; at low ratios of bacteria:
PMN, this maneuver makes it possible to distinguish bacteria adherent to
cells from those ingested and thus protected from the antibiotics by their
intracellular location. They concluded that the effect of cytochalasin B ap-
peared to be on the process of engulfment of bacteria rather than on intra-
cellular killing.
Since we employed much higher ratios of bacteria: cell than did Davis et
al., it was possible to determine how many bacteria were actually ingested.
Counts of bacteria in one-micron-thick sections indicated that both cell types
ingested fewer bacteria when treated with cytochalasin B (also, Figs. 6 and
7). Furthermore, adherent bacteria could be found, some invaginated into
the cell, but without the membrane fusion that would internalize them
(Fig. 8). Allison et al. recently noted attachment of bacteria without engulf-
ment under the light microscope, using drug-treated guinea-pig peritoneal
macrophages adherent to a surface.'
Although our current findings indicate that the drug-induced increase in
cell-associated live bacteria is due at least in part to adherent, non-ingested
bacteria, they do not rule out the additional possibility of less intracellular
killing. Moreover, such an additional effect seems likely from other evidence.
Allison et al. found that cytochalasin B stopped all movements of ruffled
membranes in macrophages and of the cells themselves, together with pino-
cytosis, and that pinosomes already formed remained immobile in what re-
mained of the pseudopods.> If endosomes in general and lysosomes in ad-
dition were to cease their usual intracellular translocations,' the expected
result would be a decrease in fusion of the two structures, possibly dramatic
enough to effect a decrease in intracellular killing. Supporting this view is
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the recent evidence that cytochalasin B interferes with the translocation of
pigment granules induced in melanocytes by melanocyte-stimulating hor-
mone."M
The failure of drug-treated cells to engulf bacteria completely may be due
to a slowing of cytoplasmic flux about the adherent micro-organism, or to a
defect in fusion of the plasmalemma after the bacterium has been sur-
rounded.T Whatever the mechanism, the failure may be a special instance
of the general effect of cytochalasin B on motility and the formation of a
ruffled membrane, first described by Carter in L cells,' and confirmed by
Allison et al. in macrophages2' and by Harris and Ramsey in human blood
PMN.' (The last workers found reversible effects, within seconds, with
0.5 ptg/ml cytochalasin B). The considerable (though subnormal) uptake
of bacteria onto the surfaces of presumably obtunded, drug-treated cells,
can be attributed to the system employed: serum (for opsonin) and buffer,
a high concentration of leukocytes, and a high ratio of bacteria:PMN,
shaken vigorously to maximize the number of "hits" and minimize the
necessity for locomotion or chemotaxis.
Metabolic studies. Cytochalasin B inhibited the conversion of glucose to
CO2 in both leukocytes and macrophages (Table 1 and Fig. 3). Several
possibilities should be considered. First, cytochalasin B may exert a non-
specific toxic effect on cell metabolism. However, few metabolic effects of
cytochalasin B are known,"' and in the present work there was no inhibition
of the oxidation of pyruvate, succinate or acetate (Table 2), or of the ac-
tivities of G6PD and 6 PGD. Furthermore, the effects of cytochalasin B
were reversible (Table 3). Second, cytochalasin B may interfere with the
active transport of glucose into these cells. This possibility is unlikely be-
cause the drug preferentially inhibited CO2 production from glucose-1-14C,
at least in the macrophage (Fig. 3). Third, the inhibition of glucose oxida-
tion may reflect the demonstrated inhibition of ingestion of bacteria. This
alternative may partially explain the effect on cells stimulated by bacteria,
but it does not explain the effect on resting cells (Table 1, Fig. 3). The lat-
ter effect could be related to interference with baseline cell motility (see
above).
Role of microfilaments. We have identified skeins of microfilaments in
ultrathin sections of both PMN and macrophages (Figs. 9 and 10). Treat-
ment of either cell type with cytochalasin B interfered with our ability to
distinguish these microfilaments. In contrast, microtubules were still present
(Fig. 11). Schroeder first noted that cytochalasin B made microfilaments
disappear in the cleavage furrow of dividing Arbacia eggs, and that furrow-
ing ceased or regressed."' Mitosis was not affected; thus, microtubules
presumably maintained their integrity. Since Carter's original observations
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on functional effects of cytochalasin B," a catalogue of effects related to
motile functions, of or within cells, has arisen through the observations of
many investigators, sometimes with documentation of ultrastructural effects
on presumably-contractile microfilament systems.' De Petris' has found, in
the peripheral or cortical cytoplasm of guinea pig peritoneal macrophages,
a network of microfilaments which, in glycerol-extracted cells, bind heavy
meromyosin, implying that they are "actin-like."tm
In summary, if we postulate that cytochalasin B has a specific direct or
indirect effect on the organization of systems of microfilaments, the current
studies would support the following functions for microfilaments: produc-
tion of the phagosome (i.e., the surrounding by the cell of an attached par-
ticle, or subsequent membrane closure, or both) and the provision of micro-
structural constraints which keep normal cells, centrifuged on to glass, from
flattening and spreading (Figs. 4 and 5), and which maintain the spatial
interrelationships of the lobes of PMN (Fig. 4). Other possible functions,
based on observations of others, are those relating to cellular motility, ex-
ternal or internal; i.e., locomotion"" and therefore chemotaxis (directed lo-
comotion), pinocytosis' (or, more generally, endocytosis), exocytosis (by
similar means), intracellular movement of endosomes' and lysosomes, and
consequently intracellular killing and digestion. Glucose oxidation, in non-
phagocyting cells, and especially glucose-1 oxidation, may be related to base-
line motility.
Relationship between microtubules and microfilaments. It is useful to
compare the suggested role of microtubules with that of microfilaments.
Microtubules also appear to be involved in structure and movement in
cells.' They have been thought possibly to perform mechanical work' and
to contribute to the strength of protoplasmic gels.' It therefore seemed
possible that in PMN, protoplasmic gels and microtubules might be involved
in locomotion," which requires frequent reversible cytoplasmic structural
alterations. Indeed, colchicine, which causes the dissolution of microtubules
in PMN,' does interfere with the motility of PMN crawling on glass,' but
compared with cytochalasin, requires many minutes rather than seconds,'
and molar concentrations 1000 times higher. However, at much lower con-
centrations, colchicine interferes with chemotaxis," which involves direction
as well as locomotion.
In addition to causing dissolution of normal microtubules," both colchi-
cine and vinblastine inhibit degranulation of PMN and the formation of
digestive vacuoles during phagocytosis, without inhibiting ingestion or in-
tracellular killing.` To correlate these activities, we turned to the work of
Freed and associates, who consider microtubules to be involved in a basic
intracellular transport system.' They studied long saltatory movements,
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which are non-Brownian displacements of cytoplasmic particles, independent
of flow of cytoplasm, and (like microtubules) generally radially directed.
Because both lysosomal granules and ingested material underwent these
movements in Freed's system, and because colchicine caused the movements
to stop, we suggested that in PMN, microtubules may facilitate the associa-
tion of lysosomes with phagosomes, to form digestive vacuoles.`'0 Inter-
ference with the normal organization of microtubules in PMN might then
be the basis for the observed effects of colchicine and vinblastine. However,
it is not clear whether the microtubules provide a motive force for the fusion
of lysosome and phagosome, or merely facilitate fusion by orienting these
structures.
A working hypothesis for the relationship between microtubules and mi-
crofilaments, similar to one proposed by others,' is that a system of labile
microtubules forms a series of oriented infrastructures against which a sys-
tem of contractile microfilaments can perform mechanical work. This bone-
and-muscle conception is surely oversimplified, but reasonably fits the data
presently available. Endocytosis, studied here, would appear primarily to
require the integrity of microfilaments, given a system in which easy con-
tact is provided between particle and cell.
SUMMARY
Cytochalasin B, which affects certain types of motility, of cells and within
cells, is currently thought to interfere rather specifically with the function
of contractile microfilaments. To study the possible role of microfilaments
in phagocytosis, we examined the effects of cytochalasin B (0.5-5 jug/ml)
on phagocytosis of Staphylococcus aureuts by human blood leukocytes and
by rabbit alveolar macrophages.
Cytochalasin B diminished the uptake of bacteria by both cell types. De-
creased numbers of intracellular bacteria were confirmed in one-micron-
thick sections of cell pellets. However, increased numbers of live, cell-as-
sociated bacteria were recovered from drug-treated cells, as compared to
controls, indicating that bacteria were adherent to cells but not ingested, or
were ingested but not normally killed, or both. Effects on uptake and killing
were reversible by diluting and washing the cells.
Cytochalasin B inhibited 14CO2 from glucose-1-14C both in resting cells
and in cells stimulated by bacteria; this effect was also reversible. In macro-
phages, 14CO2 from glucose-6-14C was depressed less than that from glucose-
1-14C in both resting and stimulated cells; 14CO2 from labelled pyruvate,
acetate and succinate was not depressed.
Cytochalasin B caused cells centrifuged on to glass slides to become flatter
and more spread out than normal, and the lobes of PMN nuclei to be less
298
Volitine 44, December, 1971Cytochalasin B inhibition of phagocytosis MALAWISTA et al.
mutually constrained (a rosette effect). In addition, microfilaments were no
longer visible in drug-treated PMN, and their incidence was markedly de-
creased in drug-treated macrophages, while microtubules remained promi-
nent.
These results suggest that contractile microfilaments may be important
for endocytosis, for the provision of certain microstructural constraints, and
possibly for other motile aspects of phagocytosis. Possible relationships be-
tween microfilaments and microtubules are discussed.
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